Prosecution Insights
Last updated: August 17, 2026

Examiner: WEDDINGTON, KEVIN E

Tech Center 1600 • Art Units: 1613 1614 1621 1629 1644

This examiner grants 75% of resolved cases

Performance Statistics

75.2%
Allow Rate
+15.2% vs TC avg
1,493
Total Applications
+10.1%
Interview Lift
900
Avg Prosecution Days
Based on 1467 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
17.0%
§102 Novelty
28.3%
§103 Obviousness
28.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18591870 POLYAMINO IODINATED COMPOUNDS AND RADIOPAQUE HYDROGELS FORMED THEREFROM Non-Final OA Boston Scientific Scimed, Inc.
18563694 Antibacterial Composition Final Rejection LG Chem, Ltd.
18249948 ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18207777 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE Non-Final OA Board of Regents of the University of Texas System
18016131 METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE Non-Final OA Cornell University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month